Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19
Open Access
- 5 June 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 854
- https://doi.org/10.3389/fphar.2020.00854
Abstract
The COVID-19 pandemic is posing an unprecedented sanitary threat. In the absence of specific vaccines and anti-SARS-CoV-2 drugs, medicines that may assist in tackling the emergency and limiting the high number of fatalities are urgently needed. The repositioning of available drugs to treat COVID-19 is the only and rapid option in the face of the lack of direct antiviral agents and vaccines available. In this light it is important to focus on available drugs, which, based on their pharmacodynamics, could plausibly attenuate viral growth as well as COVID-19's worst complications. This is the case of chloroquine and tocilizumab which seem to limit virus replication and the severity of interstitial pneumonia, respectively. However, these treatments, particularly those aimed at containing inflammation, are still reserved for the most severe cases. This commentary elaborates on the pharmacological rationale of repositioning the mast cell stabilizer chromones as an adjunctive treatment for SARS-CoV-2 infection, and proposes their practical clinical testing as an early, safe, and cost-effective anti-inflammatory intervention in COVID-19 to limit the eventual secondary progression toward life-threatening respiratory complications.Funding Information
- Università degli Studi di Urbino Carlo Bo
This publication has 45 references indexed in Scilit:
- The therapeutic effects of sodium cromoglycate against influenza A virus H5N1 in miceInfluenza and Other Respiratory Viruses, 2015
- The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cellsJournal of Allergy and Clinical Immunology, 2014
- Mast Cell Stabilization Alleviates Acute Lung Injury after Orthotopic Autologous Liver Transplantation in Rats by Downregulating InflammationPLOS ONE, 2013
- Evidence questioning cromolyn's effectiveness and selectivity as a ‘mast cell stabilizer' in miceLaboratory Investigation, 2012
- Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in HumansPLOS ONE, 2012
- Milrinone for persistent pulmonary hypertension of the newbornEmergencias, 2010
- Annexin A1 and glucocorticoids as effectors of the resolution of inflammationNature Reviews Immunology, 2009
- Annexin‐A1: a pivotal regulator of the innate and adaptive immune systemsBritish Journal of Pharmacology, 2008
- Ketotifen alone or as additional medication for long-term control of asthma and wheeze in childrenEmergencias, 2004
- Effects of Sodium Cromoglycate and Nedocromil Sodium on Histamine Secretion from Mast Cells from Various LocationsDrugs, 1989